カテゴリー： Market Monitor Global, 世界, 医療/バイオ

ヒアルロニダーゼの世界市場見通し2023年-2029年

◆英語タイトル：Hyaluronidase Market, Global Outlook and Forecast 2023-2029
	◆商品コード：MMG23LY8786 ◆発行会社（リサーチ会社）：Market Monitor Global ◆発行日：2023年7月 ◆ページ数：74 ◆レポート形式：英語 / PDF ◆納品方法：Eメール（受注後2-3営業日） ◆調査対象地域：グローバル ◆産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥487,500	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥633,750	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥731,250	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Hyaluronidase Market 調査レポートは次の情報を含め、グローバルにおけるのヒアルロニダーゼ市場規模と予測を収録しています。・世界のヒアルロニダーゼ市場：売上、2018年-2023年、2024年-2029年
・世界のヒアルロニダーゼ市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のヒアルロニダーゼ市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「動物由来ヒアルロニダーゼ」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

ヒアルロニダーゼのグローバル主要企業は、PrimaPharm、 Bausch Health、 Amphastar Pharmaceuticals、 Halozyme Therapeutics、 CooperSurgical Fertility、 Shreya Life Sciences、 Sun Pharmaceutical Industries、 CBC Pharma、 STEMCELL Technologiesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、ヒアルロニダーゼのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のヒアルロニダーゼ市場：タイプ別、2018年-2023年、2024年-2029年
世界のヒアルロニダーゼ市場：タイプ別市場シェア、2022年
・動物由来ヒアルロニダーゼ、合成ヒアルロニダーゼ

世界のヒアルロニダーゼ市場：用途別、2018年-2023年、2024年-2029年
世界のヒアルロニダーゼ市場：用途別市場シェア、2022年
・皮膚科、形成外科

世界のヒアルロニダーゼ市場：地域・国別、2018年-2023年、2024年-2029年
世界のヒアルロニダーゼ市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるヒアルロニダーゼのグローバル売上、2018年-2023年
・主要企業におけるヒアルロニダーゼのグローバル売上シェア、2022年
・主要企業におけるヒアルロニダーゼのグローバル販売量、2018年-2023年
・主要企業におけるヒアルロニダーゼのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
PrimaPharm、 Bausch Health、 Amphastar Pharmaceuticals、 Halozyme Therapeutics、 CooperSurgical Fertility、 Shreya Life Sciences、 Sun Pharmaceutical Industries、 CBC Pharma、 STEMCELL Technologies

*************************************************************

・調査・分析レポートの概要
ヒアルロニダーゼ市場の定義
市場セグメント
世界のヒアルロニダーゼ市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のヒアルロニダーゼ市場規模
世界のヒアルロニダーゼ市場規模：2022年 VS 2029年
世界のヒアルロニダーゼ市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのヒアルロニダーゼの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のヒアルロニダーゼ製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：動物由来ヒアルロニダーゼ、合成ヒアルロニダーゼ
ヒアルロニダーゼのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：皮膚科、形成外科
ヒアルロニダーゼの用途別グローバル売上・予測

・地域別市場分析
地域別ヒアルロニダーゼ市場規模 2022年と2029年
地域別ヒアルロニダーゼ売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
PrimaPharm、 Bausch Health、 Amphastar Pharmaceuticals、 Halozyme Therapeutics、 CooperSurgical Fertility、 Shreya Life Sciences、 Sun Pharmaceutical Industries、 CBC Pharma、 STEMCELL Technologies
...

Hyaluronidases are a family of enzymes that catalyse the degradation of hyaluronic acid (HA). The three main types of hyaluronidases are two classes of eukaryotic endoglycosidase hydrolases and a prokaryotic lyase-type of glycosidase.
This report aims to provide a comprehensive presentation of the global market for Hyaluronidase, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyaluronidase. This report contains market size and forecasts of Hyaluronidase in global, including the following market information:
Global Hyaluronidase Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Hyaluronidase Market Sales, 2018-2023, 2024-2029, (L)
Global top five Hyaluronidase companies in 2022 (%)
The global Hyaluronidase market was valued at US$ 823.8 million in 2022 and is projected to reach US$ 1248.1 million by 2029, at a CAGR of 6.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Animal-derived Hyaluronidase Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hyaluronidase include PrimaPharm, Bausch Health, Amphastar Pharmaceuticals, Halozyme Therapeutics, CooperSurgical Fertility, Shreya Life Sciences, Sun Pharmaceutical Industries, CBC Pharma and STEMCELL Technologies, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hyaluronidase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hyaluronidase Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (L)
Global Hyaluronidase Market Segment Percentages, by Type, 2022 (%)
Animal-derived Hyaluronidase
Synthetic Hyaluronidase
Global Hyaluronidase Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (L)
Global Hyaluronidase Market Segment Percentages, by Application, 2022 (%)
Dermatology
Plastic Surgery
Global Hyaluronidase Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (L)
Global Hyaluronidase Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hyaluronidase revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Hyaluronidase revenues share in global market, 2022 (%)
Key companies Hyaluronidase sales in global market, 2018-2023 (Estimated), (L)
Key companies Hyaluronidase sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
PrimaPharm
Bausch Health
Amphastar Pharmaceuticals
Halozyme Therapeutics
CooperSurgical Fertility
Shreya Life Sciences
Sun Pharmaceutical Industries
CBC Pharma
STEMCELL Technologies
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hyaluronidase, market overview.
Chapter 2: Global Hyaluronidase market size in revenue and volume.
Chapter 3: Detailed analysis of Hyaluronidase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hyaluronidase in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Hyaluronidase capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Hyaluronidase Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hyaluronidase Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hyaluronidase Overall Market Size
2.1 Global Hyaluronidase Market Size: 2022 VS 2029
2.2 Global Hyaluronidase Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Hyaluronidase Sales: 2018-2029
3 Company Landscape
3.1 Top Hyaluronidase Players in Global Market
3.2 Top Global Hyaluronidase Companies Ranked by Revenue
3.3 Global Hyaluronidase Revenue by Companies
3.4 Global Hyaluronidase Sales by Companies
3.5 Global Hyaluronidase Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Hyaluronidase Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Hyaluronidase Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hyaluronidase Players in Global Market
3.8.1 List of Global Tier 1 Hyaluronidase Companies
3.8.2 List of Global Tier 2 and Tier 3 Hyaluronidase Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hyaluronidase Market Size Markets, 2022 & 2029
4.1.2 Animal-derived Hyaluronidase
4.1.3 Synthetic Hyaluronidase
4.2 By Type – Global Hyaluronidase Revenue & Forecasts
4.2.1 By Type – Global Hyaluronidase Revenue, 2018-2023
4.2.2 By Type – Global Hyaluronidase Revenue, 2024-2029
4.2.3 By Type – Global Hyaluronidase Revenue Market Share, 2018-2029
4.3 By Type – Global Hyaluronidase Sales & Forecasts
4.3.1 By Type – Global Hyaluronidase Sales, 2018-2023
4.3.2 By Type – Global Hyaluronidase Sales, 2024-2029
4.3.3 By Type – Global Hyaluronidase Sales Market Share, 2018-2029
4.4 By Type – Global Hyaluronidase Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Hyaluronidase Market Size, 2022 & 2029
5.1.2 Dermatology
5.1.3 Plastic Surgery
5.2 By Application – Global Hyaluronidase Revenue & Forecasts
5.2.1 By Application – Global Hyaluronidase Revenue, 2018-2023
5.2.2 By Application – Global Hyaluronidase Revenue, 2024-2029
5.2.3 By Application – Global Hyaluronidase Revenue Market Share, 2018-2029
5.3 By Application – Global Hyaluronidase Sales & Forecasts
5.3.1 By Application – Global Hyaluronidase Sales, 2018-2023
5.3.2 By Application – Global Hyaluronidase Sales, 2024-2029
5.3.3 By Application – Global Hyaluronidase Sales Market Share, 2018-2029
5.4 By Application – Global Hyaluronidase Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Hyaluronidase Market Size, 2022 & 2029
6.2 By Region – Global Hyaluronidase Revenue & Forecasts
6.2.1 By Region – Global Hyaluronidase Revenue, 2018-2023
6.2.2 By Region – Global Hyaluronidase Revenue, 2024-2029
6.2.3 By Region – Global Hyaluronidase Revenue Market Share, 2018-2029
6.3 By Region – Global Hyaluronidase Sales & Forecasts
6.3.1 By Region – Global Hyaluronidase Sales, 2018-2023
6.3.2 By Region – Global Hyaluronidase Sales, 2024-2029
6.3.3 By Region – Global Hyaluronidase Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Hyaluronidase Revenue, 2018-2029
6.4.2 By Country – North America Hyaluronidase Sales, 2018-2029
6.4.3 US Hyaluronidase Market Size, 2018-2029
6.4.4 Canada Hyaluronidase Market Size, 2018-2029
6.4.5 Mexico Hyaluronidase Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Hyaluronidase Revenue, 2018-2029
6.5.2 By Country – Europe Hyaluronidase Sales, 2018-2029
6.5.3 Germany Hyaluronidase Market Size, 2018-2029
6.5.4 France Hyaluronidase Market Size, 2018-2029
6.5.5 U.K. Hyaluronidase Market Size, 2018-2029
6.5.6 Italy Hyaluronidase Market Size, 2018-2029
6.5.7 Russia Hyaluronidase Market Size, 2018-2029
6.5.8 Nordic Countries Hyaluronidase Market Size, 2018-2029
6.5.9 Benelux Hyaluronidase Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Hyaluronidase Revenue, 2018-2029
6.6.2 By Region – Asia Hyaluronidase Sales, 2018-2029
6.6.3 China Hyaluronidase Market Size, 2018-2029
6.6.4 Japan Hyaluronidase Market Size, 2018-2029
6.6.5 South Korea Hyaluronidase Market Size, 2018-2029
6.6.6 Southeast Asia Hyaluronidase Market Size, 2018-2029
6.6.7 India Hyaluronidase Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Hyaluronidase Revenue, 2018-2029
6.7.2 By Country – South America Hyaluronidase Sales, 2018-2029
6.7.3 Brazil Hyaluronidase Market Size, 2018-2029
6.7.4 Argentina Hyaluronidase Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hyaluronidase Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Hyaluronidase Sales, 2018-2029
6.8.3 Turkey Hyaluronidase Market Size, 2018-2029
6.8.4 Israel Hyaluronidase Market Size, 2018-2029
6.8.5 Saudi Arabia Hyaluronidase Market Size, 2018-2029
6.8.6 UAE Hyaluronidase Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 PrimaPharm
7.1.1 PrimaPharm Company Summary
7.1.2 PrimaPharm Business Overview
7.1.3 PrimaPharm Hyaluronidase Major Product Offerings
7.1.4 PrimaPharm Hyaluronidase Sales and Revenue in Global (2018-2023)
7.1.5 PrimaPharm Key News & Latest Developments
7.2 Bausch Health
7.2.1 Bausch Health Company Summary
7.2.2 Bausch Health Business Overview
7.2.3 Bausch Health Hyaluronidase Major Product Offerings
7.2.4 Bausch Health Hyaluronidase Sales and Revenue in Global (2018-2023)
7.2.5 Bausch Health Key News & Latest Developments
7.3 Amphastar Pharmaceuticals
7.3.1 Amphastar Pharmaceuticals Company Summary
7.3.2 Amphastar Pharmaceuticals Business Overview
7.3.3 Amphastar Pharmaceuticals Hyaluronidase Major Product Offerings
7.3.4 Amphastar Pharmaceuticals Hyaluronidase Sales and Revenue in Global (2018-2023)
7.3.5 Amphastar Pharmaceuticals Key News & Latest Developments
7.4 Halozyme Therapeutics
7.4.1 Halozyme Therapeutics Company Summary
7.4.2 Halozyme Therapeutics Business Overview
7.4.3 Halozyme Therapeutics Hyaluronidase Major Product Offerings
7.4.4 Halozyme Therapeutics Hyaluronidase Sales and Revenue in Global (2018-2023)
7.4.5 Halozyme Therapeutics Key News & Latest Developments
7.5 CooperSurgical Fertility
7.5.1 CooperSurgical Fertility Company Summary
7.5.2 CooperSurgical Fertility Business Overview
7.5.3 CooperSurgical Fertility Hyaluronidase Major Product Offerings
7.5.4 CooperSurgical Fertility Hyaluronidase Sales and Revenue in Global (2018-2023)
7.5.5 CooperSurgical Fertility Key News & Latest Developments
7.6 Shreya Life Sciences
7.6.1 Shreya Life Sciences Company Summary
7.6.2 Shreya Life Sciences Business Overview
7.6.3 Shreya Life Sciences Hyaluronidase Major Product Offerings
7.6.4 Shreya Life Sciences Hyaluronidase Sales and Revenue in Global (2018-2023)
7.6.5 Shreya Life Sciences Key News & Latest Developments
7.7 Sun Pharmaceutical Industries
7.7.1 Sun Pharmaceutical Industries Company Summary
7.7.2 Sun Pharmaceutical Industries Business Overview
7.7.3 Sun Pharmaceutical Industries Hyaluronidase Major Product Offerings
7.7.4 Sun Pharmaceutical Industries Hyaluronidase Sales and Revenue in Global (2018-2023)
7.7.5 Sun Pharmaceutical Industries Key News & Latest Developments
7.8 CBC Pharma
7.8.1 CBC Pharma Company Summary
7.8.2 CBC Pharma Business Overview
7.8.3 CBC Pharma Hyaluronidase Major Product Offerings
7.8.4 CBC Pharma Hyaluronidase Sales and Revenue in Global (2018-2023)
7.8.5 CBC Pharma Key News & Latest Developments
7.9 STEMCELL Technologies
7.9.1 STEMCELL Technologies Company Summary
7.9.2 STEMCELL Technologies Business Overview
7.9.3 STEMCELL Technologies Hyaluronidase Major Product Offerings
7.9.4 STEMCELL Technologies Hyaluronidase Sales and Revenue in Global (2018-2023)
7.9.5 STEMCELL Technologies Key News & Latest Developments
8 Global Hyaluronidase Production Capacity, Analysis
8.1 Global Hyaluronidase Production Capacity, 2018-2029
8.2 Hyaluronidase Production Capacity of Key Manufacturers in Global Market
8.3 Global Hyaluronidase Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hyaluronidase Supply Chain Analysis
10.1 Hyaluronidase Industry Value Chain
10.2 Hyaluronidase Upstream Market
10.3 Hyaluronidase Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hyaluronidase Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Hyaluronidase in Global Market
Table 2. Top Hyaluronidase Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Hyaluronidase Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Hyaluronidase Revenue Share by Companies, 2018-2023
Table 5. Global Hyaluronidase Sales by Companies, (L), 2018-2023
Table 6. Global Hyaluronidase Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Hyaluronidase Price (2018-2023) & (USD/mL)
Table 8. Global Manufacturers Hyaluronidase Product Type
Table 9. List of Global Tier 1 Hyaluronidase Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hyaluronidase Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Hyaluronidase Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Hyaluronidase Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Hyaluronidase Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Hyaluronidase Sales (L), 2018-2023
Table 15. By Type - Global Hyaluronidase Sales (L), 2024-2029
Table 16. By Application – Global Hyaluronidase Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Hyaluronidase Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Hyaluronidase Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Hyaluronidase Sales (L), 2018-2023
Table 20. By Application - Global Hyaluronidase Sales (L), 2024-2029
Table 21. By Region – Global Hyaluronidase Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Hyaluronidase Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Hyaluronidase Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Hyaluronidase Sales (L), 2018-2023
Table 25. By Region - Global Hyaluronidase Sales (L), 2024-2029
Table 26. By Country - North America Hyaluronidase Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Hyaluronidase Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Hyaluronidase Sales, (L), 2018-2023
Table 29. By Country - North America Hyaluronidase Sales, (L), 2024-2029
Table 30. By Country - Europe Hyaluronidase Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Hyaluronidase Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Hyaluronidase Sales, (L), 2018-2023
Table 33. By Country - Europe Hyaluronidase Sales, (L), 2024-2029
Table 34. By Region - Asia Hyaluronidase Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Hyaluronidase Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Hyaluronidase Sales, (L), 2018-2023
Table 37. By Region - Asia Hyaluronidase Sales, (L), 2024-2029
Table 38. By Country - South America Hyaluronidase Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Hyaluronidase Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Hyaluronidase Sales, (L), 2018-2023
Table 41. By Country - South America Hyaluronidase Sales, (L), 2024-2029
Table 42. By Country - Middle East & Africa Hyaluronidase Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Hyaluronidase Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Hyaluronidase Sales, (L), 2018-2023
Table 45. By Country - Middle East & Africa Hyaluronidase Sales, (L), 2024-2029
Table 46. PrimaPharm Company Summary
Table 47. PrimaPharm Hyaluronidase Product Offerings
Table 48. PrimaPharm Hyaluronidase Sales (L), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 49. PrimaPharm Key News & Latest Developments
Table 50. Bausch Health Company Summary
Table 51. Bausch Health Hyaluronidase Product Offerings
Table 52. Bausch Health Hyaluronidase Sales (L), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 53. Bausch Health Key News & Latest Developments
Table 54. Amphastar Pharmaceuticals Company Summary
Table 55. Amphastar Pharmaceuticals Hyaluronidase Product Offerings
Table 56. Amphastar Pharmaceuticals Hyaluronidase Sales (L), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 57. Amphastar Pharmaceuticals Key News & Latest Developments
Table 58. Halozyme Therapeutics Company Summary
Table 59. Halozyme Therapeutics Hyaluronidase Product Offerings
Table 60. Halozyme Therapeutics Hyaluronidase Sales (L), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 61. Halozyme Therapeutics Key News & Latest Developments
Table 62. CooperSurgical Fertility Company Summary
Table 63. CooperSurgical Fertility Hyaluronidase Product Offerings
Table 64. CooperSurgical Fertility Hyaluronidase Sales (L), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 65. CooperSurgical Fertility Key News & Latest Developments
Table 66. Shreya Life Sciences Company Summary
Table 67. Shreya Life Sciences Hyaluronidase Product Offerings
Table 68. Shreya Life Sciences Hyaluronidase Sales (L), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 69. Shreya Life Sciences Key News & Latest Developments
Table 70. Sun Pharmaceutical Industries Company Summary
Table 71. Sun Pharmaceutical Industries Hyaluronidase Product Offerings
Table 72. Sun Pharmaceutical Industries Hyaluronidase Sales (L), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 73. Sun Pharmaceutical Industries Key News & Latest Developments
Table 74. CBC Pharma Company Summary
Table 75. CBC Pharma Hyaluronidase Product Offerings
Table 76. CBC Pharma Hyaluronidase Sales (L), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 77. CBC Pharma Key News & Latest Developments
Table 78. STEMCELL Technologies Company Summary
Table 79. STEMCELL Technologies Hyaluronidase Product Offerings
Table 80. STEMCELL Technologies Hyaluronidase Sales (L), Revenue (US$, Mn) and Average Price (USD/mL) (2018-2023)
Table 81. STEMCELL Technologies Key News & Latest Developments
Table 82. Hyaluronidase Production Capacity (L) of Key Manufacturers in Global Market, 2021-2023 (L)
Table 83. Global Hyaluronidase Capacity Market Share of Key Manufacturers, 2021-2023
Table 84. Global Hyaluronidase Production by Region, 2018-2023 (L)
Table 85. Global Hyaluronidase Production by Region, 2024-2029 (L)
Table 86. Hyaluronidase Market Opportunities & Trends in Global Market
Table 87. Hyaluronidase Market Drivers in Global Market
Table 88. Hyaluronidase Market Restraints in Global Market
Table 89. Hyaluronidase Raw Materials
Table 90. Hyaluronidase Raw Materials Suppliers in Global Market
Table 91. Typical Hyaluronidase Downstream
Table 92. Hyaluronidase Downstream Clients in Global Market
Table 93. Hyaluronidase Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Hyaluronidase Segment by Type in 2022
Figure 2. Hyaluronidase Segment by Application in 2022
Figure 3. Global Hyaluronidase Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hyaluronidase Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Hyaluronidase Revenue, 2018-2029 (US$, Mn)
Figure 7. Hyaluronidase Sales in Global Market: 2018-2029 (L)
Figure 8. The Top 3 and 5 Players Market Share by Hyaluronidase Revenue in 2022
Figure 9. By Type - Global Hyaluronidase Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Hyaluronidase Revenue Market Share, 2018-2029
Figure 11. By Type - Global Hyaluronidase Sales Market Share, 2018-2029
Figure 12. By Type - Global Hyaluronidase Price (USD/mL), 2018-2029
Figure 13. By Application - Global Hyaluronidase Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Hyaluronidase Revenue Market Share, 2018-2029
Figure 15. By Application - Global Hyaluronidase Sales Market Share, 2018-2029
Figure 16. By Application - Global Hyaluronidase Price (USD/mL), 2018-2029
Figure 17. By Region - Global Hyaluronidase Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Hyaluronidase Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Hyaluronidase Revenue Market Share, 2018-2029
Figure 20. By Region - Global Hyaluronidase Sales Market Share, 2018-2029
Figure 21. By Country - North America Hyaluronidase Revenue Market Share, 2018-2029
Figure 22. By Country - North America Hyaluronidase Sales Market Share, 2018-2029
Figure 23. US Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Hyaluronidase Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Hyaluronidase Sales Market Share, 2018-2029
Figure 28. Germany Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 29. France Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Hyaluronidase Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Hyaluronidase Sales Market Share, 2018-2029
Figure 37. China Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 41. India Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Hyaluronidase Revenue Market Share, 2018-2029
Figure 43. By Country - South America Hyaluronidase Sales Market Share, 2018-2029
Figure 44. Brazil Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Hyaluronidase Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Hyaluronidase Sales Market Share, 2018-2029
Figure 48. Turkey Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Hyaluronidase Revenue, (US$, Mn), 2018-2029
Figure 52. Global Hyaluronidase Production Capacity (L), 2018-2029
Figure 53. The Percentage of Production Hyaluronidase by Region, 2022 VS 2029
Figure 54. Hyaluronidase Industry Value Chain
Figure 55. Marketing Channels

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ ヒアルロニダーゼの世界市場見通し2023年-2029年(Hyaluronidase Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

ヒアルロニダーゼの世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp